13F filer · CIK 1598803
Belmont Global Advisors, Inc.
Dallas, TX · filing since Q4 2013 · last filing Nov 14, 2016
Reported value
$105.7M
+$1.5M vs prior
Positions
69
New / sold out
32 / 27
Added / reduced
14 / 11
Turnover
36.6%
buys $38.4M · sells $42.1M
Top-10 weight
66.1%
Biggest buys vs Q2 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | POWERSHARES QQQ TRUSTPUT | +100,000 | – | +$11.9M |
| Added | ZIOPHARM ONCOLOGY INC | +407,222 | +22.4% | +$2.3M |
| New | FIREEYE INCCALL | +150,000 | – | +$2.2M |
| Added | ZIOPHARM ONCOLOGY INCCALL | +379,100 | +15.8% | +$2.1M |
| New | IMPERVA INC | +28,500 | – | +$1.5M |
| New | AIR METHODS CORPCALL | +40,000 | – | +$1.3M |
| New | BIODELIVERY SCIENCES INTL IN | +425,000 | – | +$1.1M |
| New | CYTOKINETICS INCCALL | +120,000 | – | +$1.1M |
| New | SYNERGY PHARMACEUTICALS DELCALL | +200,000 | – | +$1.1M |
| New | ALNYLAM PHARMACEUTICALS INC | +15,000 | – | +$1.0M |
36 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q2 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | SPYSPDR S&P 500 ETF TRCALL | -75,000 | -100.0% | $-15.7M |
| Reduced | ACADIA PHARMACEUTICALS INCCALL | -100,000 | -66.7% | $-3.2M |
| Sold out | PROSHARES TRCALL | -100,000 | -100.0% | $-3.2M |
| Sold out | FRONTLINE LTDCALL | -300,000 | -100.0% | $-2.4M |
| Sold out | HOME DEPOT INC | -10,050 | -100.0% | $-1.3M |
| Sold out | ACADIA PHARMACEUTICALS INC | -38,000 | -100.0% | $-1.2M |
| Sold out | PALO ALTO NETWORKS INC | -8,500 | -100.0% | $-1.0M |
| Sold out | LA JOLLA PHARMACEUTICAL CO | -60,000 | -100.0% | $-960.0K |
| Sold out | HALOZYME THERAPEUTICS INCCALL | -110,000 | -100.0% | $-949.0K |
| Sold out | CHECK POINT SOFTWARE TECH LT | -10,000 | -100.0% | $-797.0K |
28 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2016
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ZIOPHARM ONCOLOGY INCCALLCOM | 2,784,100 | $15.7M | 14.83% |
| 2 | INTREXON CORPCALLCOM | 455,000 | $12.7M | 12.06% |
| 3 | ZIOPHARM ONCOLOGY INCCOM | 2,225,262 | $12.5M | 11.85% |
| 4 | POWERSHARES QQQ TRUSTPUTUNIT SER 1 | 100,000 | $11.9M | 11.23% |
| 5 | INTREXON CORPCOM | 300,550 | $8.4M | 7.97% |
| 6 | FIREEYE INCCALLCOM | 150,000 | $2.2M | 2.09% |
| 7 | VERITEX HLDGS INCCOM | 95,404 | $1.7M | 1.57% |
| 8 | FORTRESS BIOTECH INCCOM | 545,000 | $1.6M | 1.53% |
| 9 | ACADIA PHARMACEUTICALS INCCALLCOM | 50,000 | $1.6M | 1.51% |
| 10 | IMPERVA INCCOM | 28,500 | $1.5M | 1.45% |
59 more rows. Subscribe for $29/month to see every row, download the data and use the API.